Share on StockTwits

Otonomy (NASDAQ:OTIC) Director Jay Lichter sold 50,001 shares of the company’s stock on the open market in a transaction dated Monday, August 18th. The shares were sold at an average price of $16.00, for a total transaction of $800,016.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Otonomy (NASDAQ:OTIC) traded down 1.06% on Tuesday, hitting $15.84. 200,800 shares of the company’s stock traded hands. Otonomy has a 52 week low of $15.19 and a 52 week high of $18.49. The stock has a 50-day moving average of $16.3 and a 200-day moving average of $16.3. The company’s market cap is $2.0 million.

Otonomy, Inc is a clinical-stage biopharmaceutical company. The Company focused on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.